(Press release) Bayer HealthCare Pharmaceuticals has chosen OncoGenomics Explorer as their solution for utilizing oncology Big Data. Finnish MediSapiens’ software will provide Bayer a new cloud computing application to analyze and visualize multi-dimensional genomics data.
MediSapiens Ltd, a Finnish company developing web-based data applications for the pharmaceutical industry, today announced that Bayer HealthCare Pharmaceuticals has purchased a new software solution developed by MediSapiens. The software, called OncoGenomics Explorer will provide Bayer HealthCare Pharmaceuticals with a centralized access to unified global genomics data for utilization across the entire research organization from target discovery to drug repositioning.
Read the whole press release in www.medisapiens.com
